Sara
Zalba Oteiza
Colaboradora de Investigación
Erasmus University Medical Center
Róterdam, HolandaPublicaciones en colaboración con investigadores/as de Erasmus University Medical Center (10)
2024
-
Lipid-based nanosystems: the next generation of cancer immune therapy
Journal of Hematology and Oncology, Vol. 17, Núm. 1
2022
-
Stealth nanoparticles in oncology: Facing the PEG dilemma
Journal of Controlled Release, Vol. 351, pp. 22-36
2021
-
Drug transport kinetics of intravascular triggered drug delivery systems
Communications Biology, Vol. 4, Núm. 1
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1
2020
-
Sensitization of drug resistant sarcoma tumors by membrane modulation: Via short chain sphingolipid-containing nanoparticles
Nanoscale, Vol. 12, Núm. 32, pp. 16967-16979
2019
-
A new immune-nanoplatform for promoting adaptive antitumor immune response
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 13-25
-
Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response
International Journal of Nanomedicine, Vol. 14, pp. 2069-2089
2017
-
Cell membrane modulation as adjuvant in cancer therapy
Cancer Treatment Reviews, Vol. 52, pp. 48-57
2016
-
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model
Nanomedicine, Vol. 11, Núm. 5, pp. 465-477
-
Targeting melanoma with immunoliposomes coupled to anti-MAGEAI TCR-like single-chain antibody
International Journal of Nanomedicine, Vol. 11, pp. 955-975